Providence Sacred Heart Medical Center & Children's Hospital is a 648-bed general hospital in Spokane, Washington. It employs more than 4,000 health care professionals and support staff; its medical staff consists of over 800 specialists and primary care doctors.

There are 648 beds in Providence Sacred Heart Medical Center and Children's Hospital.

During the past decade, Providence Sacred Heart Medical Center and Children's Hospital conducted 126 clinical trials. In the 10-year time frame, 126 clinical trials started and 105 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 55 clinical trials were completed. i.e. 127.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Sacred Heart Medical Center and Children's Hospital" #1 sponsor was "Children's Oncology Group" with 84 trials, followed by "National Cancer Institute (NCI)" with 65 trials sponsored, "Abbott Medical Devices" with 8 trials sponsored, "Boston Scientific Corporation" with 8 trials sponsored and "Medtronic Cardiovascular" with 8 trials sponsored. Other sponsors include 91 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Sacred Heart Medical Center and Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 7 trials as a collaborator, "Children's Oncology Group" with 6 trials as a collaborator, "Boston Scientific Corporation" with 3 trials as a collaborator and "Medtronic" with 3 trials as a collaborator. Other collaborators include 107 different institutions and companies that were collaborators in the rest 96 trials.

According to Clinical.Site data, the most researched conditions in "Providence Sacred Heart Medical Center and Children's Hospital" are "Recurrent Neuroblastoma" (22 trials), "Recurrent Osteosarcoma" (19 trials), "Refractory Neuroblastoma" (15 trials), "Recurrent Malignant Solid Neoplasm" (14 trials) and "Refractory Malignant Solid Neoplasm" (14 trials). Many other conditions were trialed in "Providence Sacred Heart Medical Center and Children's Hospital" in a lesser frequency.

Most popular intervention types in "Providence Sacred Heart Medical Center and Children's Hospital" are "Drug" (158 trials), "Other" (121 trials), "Procedure" (64 trials), "Biological" (59 trials) and "Device" (59 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Cyclophosphamide" (42 trials), "Vincristine Sulfate" (37 trials), "Questionnaire Administration" (32 trials) and "Doxorubicin Hydrochloride" (28 trials). Other intervention names were less common.

The vast majority of trials in "Providence Sacred Heart Medical Center and Children's Hospital" are 257 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Sacred Heart Medical Center and Children's Hospital". undefined are not yet recruiting, 47 are recruiting, 80 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 105 completed trials in Providence Sacred Heart Medical Center and Children's Hospital, 2 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Sacred Heart Medical Center and Children's Hospital, 9 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 101 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 38 trials that are defined as “Not Applicable".